ROSA MARÍA
AYALA DÍAZ
Profesora asociada de Ciencias de la Salud
JOAQUÍN
MARTÍNEZ LÓPEZ
Catedrático de universidad
Publicaciones en las que colabora con JOAQUÍN MARTÍNEZ LÓPEZ (71)
2023
-
Biallelic TET2 mutations confer sensitivity to 5′-azacitidine in acute myeloid leukemia
JCI Insight, Vol. 8, Núm. 2
-
CNL and aCML should be considered as a single entity based on molecular profiles and outcomes
Blood Advances, Vol. 7, Núm. 9, pp. 1672-1681
-
Clinical Outcomes of Patients with Multiple Myeloma after Daratumumab Failure
Life, Vol. 13, Núm. 9
-
Correction: Large-scale real-life analysis of survival and usage of therapies in multiple myeloma (Journal of Hematology & Oncology, (2023), 16, 1, (76), 10.1186/s13045-023-01474-w)
Journal of Hematology and Oncology
-
Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients
Frontiers in immunology
-
Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients (Frontiers in Immunology, (2023), 14, (1188818), 10.3389/fimmu.2023.1188818)
Frontiers in Immunology
-
Large-scale real-life analysis of survival and usage of therapies in multiple myeloma
Journal of Hematology and Oncology
-
Multidisciplinary management in chronic myeloid leukemia improves cardiovascular risk measured by SCORE
Frontiers in Pharmacology, Vol. 14
-
Posttranslational splicing modifications as a key mechanism in cytarabine resistance in acute myeloid leukemia
Leukemia, Vol. 37, Núm. 8, pp. 1649-1659
-
Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CT
Leukemia, Vol. 37, Núm. 3, pp. 659-669
-
Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia
British Journal of Haematology
2022
-
Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA
Scientific Reports, Vol. 12, Núm. 1
-
Impact of FLT3–ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study
Cancers, Vol. 14, Núm. 23
-
NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial
Cancers, Vol. 14, Núm. 20
-
No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group
Disease markers, Vol. 2022, pp. 3132941
-
Outcomes and patterns of treatment in chronic myeloid leukemia, a global perspective based on a real-world data global network
Blood Cancer Journal, Vol. 12, Núm. 6
-
The Minimal Residual Disease Using Liquid Biopsies in Hematological Malignancies
Cancers, Vol. 14, Núm. 5
-
The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patients
Frontiers in Oncology, Vol. 12
2021
-
A typical acute lymphoblastic leukemia JAK2 variant, R683G, causes an aggressive form of familial thrombocytosis when germline
Leukemia, Vol. 35, Núm. 11, pp. 3295-3298
-
Clonal hematopoiesis-defining mutations have no impact on the development of thrombosis in a cohort of patients with myeloid pathology
Leukemia Research